CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Conversion Chief Science/Medical Officer acquired 85,000 shares (conversion)
- 4 Conversion Exec. Vice Chairman/CEO/Pres. acquired 552,500 shares (conversion)
- 4 Conversion CFO acquired 85,000 shares (conversion)
- 4 Other acquisition Director acquired 108,608 shares (other)
- 4 Other acquisition Director acquired 108,608 shares (other)
- 4 Open-market buy Exec. Vice Chairman/CEO/Pres. bought 13,400 shares at $0.18 ($2,352)
- 4 Option exercise Director acquired 200,040 shares (option exercise)
- 4 Option exercise Director acquired 200,040 shares (option exercise)
- 4 Option exercise Sr. VP of Operations acquired 50,010 shares (option exercise)
- 4 Option exercise Chief Science/Medical Officer acquired 50,010 shares (option exercise)
- 4 Option exercise Dir Govt Relations/Sectry acquired 90,018 shares (option exercise)
- 4 Option exercise Exec. Vice Chairman/CEO/Pres. acquired 325,065 shares (option exercise)
- 4 Option exercise CFO acquired 50,010 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 31 · 615 filings